Analyze Diet
The Journal of infection1999; 38(1); 22-23; doi: 10.1016/s0163-4453(99)90023-3

Transmissibility from horses to humans of a novel paramyxovirus, equine morbillivirus (EMV).

Abstract: Determination of potential infectivity of a new paramyxovirus equine morbillivirus (EMV) from horses to humans and humans to humans as a result of two outbreaks in Queensland which involved 23 horses and three humans. Methods: Seroepidemiological testing using neutralizing and immunofluorescing antibodies on people with variable levels of exposure to infected horses and humans. Results: All serological testing on a total of 298 individual contacts was negative. Conclusions: While the three human cases of EMV were probably infected as a result of very close contact with horses, these data suggest that infectivity from horses or humans is very low.
Publication Date: 1999-03-25 PubMed ID: 10090501DOI: 10.1016/s0163-4453(99)90023-3Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper examines the potential for a newly discovered paramyxovirus, the Equine Morbillivirus (EMV), to be transmitted from horses to humans and from one human to another. The study found that the risk of the virus transmission is relatively low, with all tests on people who were exposed to the virus coming out negative.

Research Context

  • The research was initiated after two outbreaks in Queensland which involved 23 horses and three humans. These were cases of infections with a novel paramyxovirus, Equine Morbillivirus (EMV).
  • Paramyxoviruses are a family of viruses which includes measles and mumps in humans and distemper in dogs.
  • The researchers wanted to determine if the newly discovered EMV could be transmitted from horses to humans and further, from humans to humans. Hence, they conducted seroepidemiological testing using neutralizing and immunofluorescing antibodies on individuals who were exposed to infected horses and humans.

Methodology and Results

  • The researchers performed seroepidemiological testing using neutralizing and immunofluorescing antibodies on people with variable levels of exposure to infected horses and humans.
  • A total of 298 individuals who had some form of contact with the infected horses or humans were tested for EMV infection.
  • The results showed that all serological tests were negative, indicating that none of the tested individuals had contracted the EMV.

Conclusions

  • From the results, researchers inferred that the three human cases of EMV were probably infected as a result of very close contact with infected horses.
  • Moreover, based on the negative serological tests for all 298 tested individuals, the study concluded that the chance of transmission either from horses or humans is very low. This suggests that the EMV is not easily transmissible between horse-human or human-human, despite instances of infection in closely associated individuals.

Cite This Article

APA
McCormack JG, Allworth AM, Selvey LA, Selleck PW. (1999). Transmissibility from horses to humans of a novel paramyxovirus, equine morbillivirus (EMV). J Infect, 38(1), 22-23. https://doi.org/10.1016/s0163-4453(99)90023-3

Publication

ISSN: 0163-4453
NlmUniqueID: 7908424
Country: England
Language: English
Volume: 38
Issue: 1
Pages: 22-23

Researcher Affiliations

McCormack, J G
  • University Department of Medicine/Infectious Diseases, Mater Hospital, South Brisbane, Queensland, Australia.
Allworth, A M
    Selvey, L A
      Selleck, P W

        MeSH Terms

        • Animals
        • Horse Diseases / transmission
        • Horse Diseases / virology
        • Horses / virology
        • Humans
        • Morbillivirus / pathogenicity
        • Morbillivirus Infections / mortality
        • Morbillivirus Infections / pathology
        • Morbillivirus Infections / transmission

        Citations

        This article has been cited 4 times.
        1. Oguntuyo KY, Haas GD, Azarm KD, Stevens CS, Brambilla L, Kowdle SS, Avanzato VA, Pryce R, Freiberg AN, Bowden TA, Lee B. Structure-guided mutagenesis of Henipavirus receptor-binding proteins reveals molecular determinants of receptor usage and antibody-binding epitopes. J Virol 2024 Mar 19;98(3):e0183823.
          doi: 10.1128/jvi.01838-23pubmed: 38426726google scholar: lookup
        2. Satterfield BA, Mire CE, Geisbert TW. Overview of Experimental Vaccines and Antiviral Therapeutics for Henipavirus Infection. Methods Mol Biol 2023;2682:1-22.
          doi: 10.1007/978-1-0716-3283-3_1pubmed: 37610570google scholar: lookup
        3. Wong KT. Emerging epidemic viral encephalitides with a special focus on henipaviruses. Acta Neuropathol 2010 Sep;120(3):317-25.
          doi: 10.1007/s00401-010-0720-zpubmed: 20652579google scholar: lookup
        4. Bender JB, Tsukayama DT. Horses and the risk of zoonotic infections. Vet Clin North Am Equine Pract 2004 Dec;20(3):643-53.
          doi: 10.1016/j.cveq.2004.07.003pubmed: 15519824google scholar: lookup